Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Caribou Biosciences Inc
(NQ:
CRBU
)
2.320
+0.020 (+0.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Caribou Biosciences Inc
< Previous
1
2
3
4
5
6
7
Next >
3 Gene-Editing Stocks With the Potential to Mint Millionaires
December 13, 2023
Gene editing stocks are very likely to see a spike in demand over the coming weeks in the wake of FDA approval of CRISPR.
Via
InvestorPlace
Exposures
Product Safety
Caribou Biosciences Provides Regulatory Update on CB-010 Pivotal Plan with Phase 3 Trial Initiation Expected by YE 2024
December 12, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy
December 07, 2023
These three gene therapy stocks should get huge boosts over the long term from the use of gene editing techniques to treat diseases.
Via
InvestorPlace
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.
Via
The Motley Fool
Where Caribou Biosciences Stands With Analysts
July 26, 2023
Via
Benzinga
2 Stocks I'm Buying on the Dip This Week
July 17, 2023
Caribou Biosciences and AT&T screen as incredible bargains for patient investors.
Via
The Motley Fool
Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On Friday
November 17, 2023
U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Caribou Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
November 07, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences Announces Appointment of Sundar Jagannath, MD, to its Scientific Advisory Board
November 06, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences to Participate in Upcoming Investor Conferences
November 01, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 06, 2023
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge...
Via
Benzinga
2 Top Growth Stocks to Buy Right Now Without Hesitation
October 20, 2023
These stocks are dirt cheap right now.
Via
The Motley Fool
Caribou Biosciences Announces FDA Clearance of IND Application for CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
October 18, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
2 Exciting Biotech Stocks to Buy With Less Than $10
October 11, 2023
You can pick up these stocks for a song right now.
Via
The Motley Fool
Big Pharma Could Transform Into BioTech Pharma
October 10, 2023
As the word itself says, biotechnology is simply technology based on biology. It uses the knowledge of cellular and biomolecular processes to develop technologies that improve our lives and overall...
Via
Benzinga
A Bull Market Is Coming: 1 Beaten-Down Growth Stock You Could Regret Not Buying on the Dip
October 10, 2023
Wall Street price targets suggest this stock can rocket more than 400% higher.
Via
The Motley Fool
2 Magnificent Growth Stocks to Buy On the Dip
September 27, 2023
It might be time to catch these falling knives.
Via
The Motley Fool
Caribou Biosciences Appoints Reigin Zawadzki as Chief People Officer
September 27, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
1 Gene Editing Stock to Buy Now, and 1 to Sell
September 23, 2023
Target markets matter. So does having the cash to get to them.
Via
The Motley Fool
Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday
September 18, 2023
U.S. stocks traded mostly flat on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Caribou Biosciences to Participate in Upcoming Investor Conferences
August 29, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
3 Clever Tricks to Find Winning Biotech Stocks
August 24, 2023
You'll need to dig into company details, but the effort is worthwhile.
Via
The Motley Fool
Caribou Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update
August 08, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
3 Reasons Why Caribou Biosciences Is a Screaming Buy in July and Beyond
July 28, 2023
Early-stage biotechs almost never warrant this level of enthusiasm.
Via
The Motley Fool
NXP Semiconductors To Rally Over 19%? Here Are 10 Other Analyst Forecasts For Wednesday
July 26, 2023
HC Wainwright & Co. cut the price target for Caribou Biosciences, Inc. (NASDAQ: CRBU) from $25 to $23. HC Wainwright & Co. analyst Robert Burns maintained a Buy rating. Caribou Biosciences shares fell...
Via
Benzinga
This 1 Innovation Could Make These 2 Biotechs Soar by 2030
July 22, 2023
Simplifying the cell therapy manufacturing process could be worth a lot of money.
Via
The Motley Fool
Got $1,000? Buying Caribou Biosciences Stock Right Now Could Be a Brilliant Move in 5 Years
July 21, 2023
It's still early going, but this small biotech shows great promise.
Via
The Motley Fool
2 Growth Stocks That Could Rocket 81% to 233% Higher, According to Wall Street
July 20, 2023
The investment bank analysts who follow these stocks think they could deliver enormous gains in the not-so-distant future.
Via
The Motley Fool
MarketBeat Week in Review – 7/10 - 7/14
July 15, 2023
As inflation moderates, Investors are optimistic for the second quarter earnings season and that optimism is evident in some of the top stories from this week
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
12 Health Care Stocks Moving In Friday's Intraday Session
July 14, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.